{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:22:59Z","timestamp":1783113779117,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015613","name":"Lille University Hospital","doi-asserted-by":"publisher","award":["NCT01784289"],"award-info":[{"award-number":["NCT01784289"]}],"id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabet.2026.101762","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:47:37Z","timestamp":1777333657000},"page":"101762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0052-4675","authenticated-orcid":false,"given":"Hippolyte","family":"Dupuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Jannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Vankemmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cortet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2026.101762_bib0001","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13023-022-02308-7","article-title":"Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)","volume":"17","author":"Mosbah","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.diabet.2026.101762_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2025.101730","article-title":"Lipodystrophy and severe insulin resistance syndrome: Epidemiological data from a French national rare diseases registry","volume":"86","author":"Vantyghem","year":"2025","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.diabet.2026.101762_bib0003","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-pathol-042220-034240","article-title":"Molecular pathology of laminopathies","volume":"17","author":"Shin","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.diabet.2026.101762_bib0004","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diabet.2018.09.006","article-title":"Cardiometabolic assessment of lamin A\/C gene mutation carriers: a phenotype-genotype correlation","volume":"45","author":"Kwapich","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2026.101762_bib0005","doi-asserted-by":"crossref","first-page":"e2217","DOI":"10.1210\/clinem\/dgae761","article-title":"Rare variation in LMNA underlies polycystic ovary syndrome pathogenesis in 2 independent cohorts","volume":"110","author":"Bauer","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2026.101762_bib0006","doi-asserted-by":"crossref","first-page":"e3617","DOI":"10.1210\/clinem\/dgaf173","article-title":"Efficacy and safety of obeticholic acid for treating hepatic steatosis in patients with familial partial lipodystrophy","volume":"110","author":"Garg","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2026.101762_bib0007","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.3390\/nu13093168","article-title":"Metabolic profile and bone status in post-menopausal women with rheumatoid arthritis: a monocentric retrospective survey","volume":"13","author":"Paolino","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.diabet.2026.101762_bib0008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/nu8060347","article-title":"The relationship between metabolic syndrome and osteoporosis: a review","volume":"8","author":"Wong","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.diabet.2026.101762_bib0009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-025-01341-5","article-title":"Fracture risk assessment in metabolic syndrome in terms of secondary osteoporosis potential. a narrative review","volume":"116","author":"Armutcu","year":"2025","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.diabet.2026.101762_bib0010","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3389\/fimmu.2018.02573","article-title":"Lack of adipocytes alters hematopoiesis in lipodystrophic mice","volume":"9","author":"Wilson","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabet.2026.101762_bib0011","article-title":"The cell biology of bone metabolism","volume":"61","author":"Hk","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.diabet.2026.101762_bib0012","article-title":"Sclerostin and osteocalcin: candidate bone-produced hormones","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabet.2026.101762_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117238","article-title":"The role of bone in energy metabolism: a focus on osteocalcin","volume":"188","author":"Smith","year":"2024","journal-title":"Bone"},{"key":"10.1016\/j.diabet.2026.101762_bib0014","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3803\/EnM.2023.1895","article-title":"Osteocalcin: beyond bones","volume":"39","author":"Nowicki","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.diabet.2026.101762_bib0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.cell.2011.02.004","article-title":"Endocrine regulation of male fertility by the skeleton","volume":"144","author":"Oury","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.diabet.2026.101762_bib0016","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.3390\/ijms20225525","article-title":"The regulation of bone metabolism and disorders by Wnt signaling","volume":"20","author":"Maeda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabet.2026.101762_bib0017","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev-biochem-040320-103615","article-title":"The Wnt pathway: from signaling mechanisms to synthetic modulators","volume":"91","author":"Rim","year":"2022","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.diabet.2026.101762_bib0018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nyas.13945","article-title":"Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging","volume":"1442","author":"Chen","year":"2019","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.diabet.2026.101762_bib0019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.steroids.2014.03.004","article-title":"Wnt\/\u03b2-catenin signaling pathway and lipolysis enzymes participate in methylprednisolone induced fat differential distribution between subcutaneous and visceral adipose tissue","volume":"84","author":"Xiao","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.diabet.2026.101762_bib0020","doi-asserted-by":"crossref","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","article-title":"Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes","volume":"114","author":"Kim","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diabet.2026.101762_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115694","article-title":"The role of sclerostin in lipid and glucose metabolism disorders","volume":"215","author":"Jiang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.diabet.2026.101762_bib0022","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1210\/jc.2012-1218","article-title":"Association of circulating sclerostin levels with fat mass and metabolic disease\u2013related markers in Japanese postmenopausal women","volume":"97","author":"Urano","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2026.101762_bib0023","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and Insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2026.101762_bib0024","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","article-title":"Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances","volume":"10","author":"Xue","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.diabet.2026.101762_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008244","article-title":"Congenital lipodystrophy induces severe osteosclerosis","volume":"15","author":"Zou","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/j.diabet.2026.101762_bib0026","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.3390\/ijerph18189724","article-title":"Bone mineral density in congenital generalized lipodystrophy: the role of bone marrow tissue, adipokines, and insulin resistance","volume":"18","author":"Freire","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.diabet.2026.101762_bib0027","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/jpgm.jpgm_1031_21","article-title":"Unusual magnetic resonance imaging findings of cystic bone lesions in congenital generalized lipodystrophy","volume":"68","author":"T de Oliveira","year":"2022","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.diabet.2026.101762_bib0028","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/genes12101508","article-title":"Two decades after mandibuloacral dysplasia discovery: additional cases and comprehensive view of disease characteristics","volume":"12","author":"J\u00e9ru","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.diabet.2026.101762_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13903","article-title":"Bone dysplasia in Hutchinson-Gilford progeria syndrome is associated with dysregulated differentiation and function of bone cell populations","volume":"22","author":"Cabral","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.diabet.2026.101762_bib0030","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/ajmg.a.63335","article-title":"A recurrent homozygous LMNA missense variant p.Thr528Met causes atypical progeroid syndrome characterized by mandibuloacral dysostosis, severe muscular dystrophy, and skeletal deformities","volume":"191","author":"Saadi","year":"2023","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.diabet.2026.101762_bib0031","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1038\/s41467-020-18146-9","article-title":"Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology","volume":"11","author":"Elouej","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabet.2026.101762_bib0032","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00256-016-2457-9","article-title":"Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases","volume":"45","author":"Teboul-Cor\u00e9","year":"2016","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.diabet.2026.101762_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cen.13504","article-title":"Bone mineral density in familial partial lipodystrophy","volume":"88","author":"Fern\u00e1ndez-Pombo","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.diabet.2026.101762_bib0034","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.EJ20-0325","article-title":"Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of \u201cHSCT-associated lipodystrophy","volume":"68","author":"Adachi","year":"2021","journal-title":"Endocr J"},{"key":"10.1016\/j.diabet.2026.101762_bib0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41375-021-01428-6","article-title":"Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells","volume":"36","author":"Kobari","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.diabet.2026.101762_bib0036","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cells8050441","article-title":"Systemic dysfunction of osteoblast differentiation in adipose-derived stem cells from patients with multiple myeloma","volume":"8","author":"B\u00e9r\u00e9ziat","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.diabet.2026.101762_bib0037","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/1756-185X.14539","article-title":"Using imaging methods to assess severe calcinosis in juvenile dermatomyositis: a case report","volume":"26","author":"Xu","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.diabet.2026.101762_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713118","article-title":"Refining evaluation of bone mass and adipose distribution in dunnigan syndrome","volume":"24","author":"Moreira","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabet.2026.101762_bib0039","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/EJE-13-0327","article-title":"Genetics in endocrinology: genetic forms of severe insulin resistance: what endocrinologists should know","volume":"169","author":"Parker","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabet.2026.101762_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1392675","article-title":"Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait","volume":"15","author":"Alramah","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabet.2026.101762_bib0041","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ando.2024.05.015","article-title":"Partial lipodystrophy: Clinical presentation and treatment","volume":"85","author":"Mosbah","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.diabet.2026.101762_bib0042","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-025-01301-2","article-title":"Diagnosis and management of genetic lipodystrophy syndromes and its implications for atherosclerosis","volume":"27","author":"Lima","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.diabet.2026.101762_bib0043","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/ATVBAHA.113.301933","article-title":"Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction","volume":"33","author":"Bidault","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2026.101762_bib0044","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/jc.2018-02730","article-title":"Comorbidities and survival in patients with lipodystrophy: an international chart review study","volume":"104","author":"Akinci","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2026.101762_bib0045","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/ATVBAHA.122.317635","article-title":"Role of sclerostin in cardiovascular disease","volume":"42","author":"Golledge","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2026.101762_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1539411","article-title":"Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt\/LRP5\/\u03b2-catenin signaling pathway","volume":"16","author":"Tian","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabet.2026.101762_bib0047","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fendo.2017.00098","article-title":"The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms","volume":"8","author":"Zhao","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabet.2026.101762_bib0048","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12944-017-0592-5","article-title":"Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model","volume":"16","author":"Shi","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabet.2026.101762_bib0049","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bbrc.2019.10.048","article-title":"Fenofibrate induces PPAR\u03b1 and BMP2 expression to stimulate osteoblast differentiation","volume":"520","author":"Kim","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabet.2026.101762_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2006.07.029","article-title":"PPAR agonists modulate human osteoclast formation and activity in vitro","volume":"40","author":"Chan","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.diabet.2026.101762_bib0051","doi-asserted-by":"crossref","first-page":"e3631","DOI":"10.1002\/dmrr.3631","article-title":"Factors associated with fragility fractures in type 2 diabetes: An analysis of the randomised controlled Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study","volume":"39","author":"Sheu","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2026.101762_bib0052","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/ijms23031639","article-title":"Bone health in patients with dyslipidemias: an underestimated aspect","volume":"23","author":"Anagnostis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabet.2026.101762_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156053","article-title":"Evidence from clinical studies of leptin: current and future clinical applications in humans","volume":"161","author":"Perakakis","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2026.101762_bib0054","article-title":"Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Chen","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabet.2026.101762_bib0055","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.3390\/ijms26104552","article-title":"Role of sclerostin in cardiovascular system","volume":"26","author":"Zhang","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363626000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363626000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:54:45Z","timestamp":1783112085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363626000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1262363626000418"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2026.101762","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2026.101762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101762"}}